布西丁

布西丁
临床资料
ATC码	N02BE04 (WHO) ;
识别信息
	IUPAC命名法 N-(4-Ethoxyphenyl)-3-hydroxybutanamide; ;
CAS号	1083-57-4
PubChem CID	14130;
ChemSpider	13507;
UNII	6M7CVQ8PF8;
ChEMBL	ChEMBL1697856;
CompTox Dashboard（英语：CompTox Chemicals Dashboard） (EPA)	DTXSID6020721 ;
ECHA InfoCard	100.012.827
化学信息
化学式	C12H17NO3
摩尔质量	223.27 g·mol−1
3D模型（JSmol（英语：JSmol））	交互式图像;
	SMILES O=C(Nc1ccc(OCC)cc1)CC(O)C;
	InChI InChI=1S/C12H17NO3/c1-3-16-11-6-4-10(5-7-11)13-12(15)8-9(2)14/h4-7,9,14H,3,8H2,1-2H3,(H,13,15); Key:LIAWQASKBFCRNR-UHFFFAOYSA-N;

布西丁（英语：Bucetin）是一种曾经用于镇痛退热的药物。^[1]^[2]从化学结构上来看，布西丁和非那西丁相似，并且都有引发癌变的风险。^[3]由于其肾毒性，布西丁于1986年被撤回。^[4]

参见

^ J. Elks. The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. 14 November 2014: 184– [2021-04-12]. ISBN 978-1-4757-2085-3. （原始内容存档于2021-04-12）.
^ WHOCC - ATC/DDD Index. WHO Collaborating Centre for Drug Statistics Methodology. December 19, 2013 [2021-04-12]. （原始内容存档于2021-01-28）.
^ Togei K, Sano N, Maeda T, Shibata M, Otsuka H. Carcinogenicity of bucetin in (C57BL/6 X C3H)F1 mice. Journal of the National Cancer Institute. November 1987, 79 (5): 1151–8. PMID 3479641. doi:10.1093/jnci/79.5.1151.
^ Fung M, Thornton A, Mybeck K, Wu JH, Hornbuckle K, Muniz E. Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999. Drug Information Journal. 2001, 35: 293–317. doi:10.1177/009286150103500134.